Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Hyperfine, Inc. (HYPR : NSDQ)

• Company Description    Hyperfine Inc. is a groundbreaking medical device company which created Swoop(R), first FDA-cleared portable MRI system(TM). Hyperfine Inc., formerly known as HealthCor Catalio Acquisition Corp., is based in GUILFORD, Conn. Number of Employees: 111

• Price / Volume Information    Yesterday's Closing Price: $1.75 Daily Weekly Monthly 20 Day Moving Average: 442,416 shares Shares Outstanding: 78.58 (millions) Market Capitalization: $137.52 (millions) Beta: 1.10 52 Week High: $2.19 52 Week Low: $0.53 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 23.24% 23.84% 12 Week 90.20% 82.77% Year To Date 98.86% 78.50%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 351 NEW WHITFIELD STREET - GUILFORD,CT 06437 USA ph: 866-796-6767 fax: - webb@gilmartinir.com https://hyperfine.io

• General Corporate Information    Officers Maria Sainz - Chief Executive Officer; President and Director R. Scott Huennekens - Chairperson of the Board Brett Hale - Chief Administrative Officer; Chief Financial Offi Jonathan M. Rothberg - Director John Dahldorf - Director Peer Information Hyperfine, Inc. (ABMD) Hyperfine, Inc. (DMDS) Hyperfine, Inc. (CPWY.) Hyperfine, Inc. (EQUR) Hyperfine, Inc. (ECIA) Hyperfine, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 44916K106 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/11/25 Share - Related Items Shares Outstanding: 78.58 Most Recent Split Date: (:1) Beta: 1.10 Market Capitalization: $137.52 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.09 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.43 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.91 Price/Cash Flow: - Price / Sales: 12.74 EPS Growth vs. Year Ago Period: 14.29% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: -25.75% vs. Previous Quarter: 26.16% ROE 09/30/25 - - 06/30/25 - -84.82 03/31/25 - -74.19 ROA 09/30/25 - - 06/30/25 - -69.39 03/31/25 - -62.40 Current Ratio 09/30/25 - - 06/30/25 - 5.02 03/31/25 - 6.07 Quick Ratio 09/30/25 - - 06/30/25 - 4.41 03/31/25 - 5.48 Operating Margin 09/30/25 - - 06/30/25 - -364.54 03/31/25 - -343.42 Net Margin 09/30/25 - - 06/30/25 - -364.54 03/31/25 - -343.42 Pre-Tax Margin 09/30/25 - - 06/30/25 - -364.54 03/31/25 - -343.42 Book Value 09/30/25 - - 06/30/25 - 0.45 03/31/25 - 0.55 Inventory Turnover 09/30/25 - - 06/30/25 - 1.05 03/31/25 - 1.01 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©